ArticleBiotechnology for biofuels and bioproducts2026
Reverse prediction of carbohydrate esterase polysaccharide targets.
Article in Biotechnology for biofuels and bioproducts, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundCarbohydrate esterases (CEs) catalyze the selective removal of ester-linked substituents from complex polysaccharides, influencing biomass bioprocessing. Predicting CE substrate specificity remains challenging due to the functional diversity and limited experimental characterization of CEs. Classic full sequence-based alignment approaches often fail to capture functional nuances across distant homologs.
resultsHere, we introduce a reverse prediction framework that leverages genomic context, specifically polysaccharide utilization loci (PULs), to infer natural polysaccharide targets of CE families. By integrating motif-based functional groups with large-scale co-occurrence analysis across Bacteroidota genomes, we identify substrate preferences at the clade level for 20 CE families. Subdivision of families into clades mitigated any polyspecificity observed when families were treated as a whole, highlighted unexplored regions within CE1, CE2, CE3, CE6, CE7, CE14, CE15, CE19, CE20, and partly within CE8 and CE12, and expanded functional coverage by up to 50% compared to characterized members alone.
conclusionsThe approach and the data reveal substantial functional subdivision of the CE families, enabling prediction of specific targets including arabinoxylan, β-mannan, pectin sub-structures, and glycosaminoglycans. Reverse prediction thus offers a powerful tool for guiding enzyme discovery and designing tailored enzyme cocktails for biomass valorization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.